EATONTOWN, N.J., Oct. 8 /PRNewswire-FirstCall/ -- QMed, Inc., (Nasdaq: QMED) today announced that it has extended its agreement with a health plan customer for an additional three years. Under the terms of the agreement, QMed will continue to provide its interventions for stroke and coronary heart disease. In addition, the Company receives a bonus of $550,000 for having achieved specific quality and financial performance measures.
Jane Murray, QMed president and CEO said, "We are obviously gratified to continue our relationship with this health plan. Just as importantly, and consistent with our historical experience, our interventions have shown positive health and financial outcomes in both commercial and Medicare populations," she concluded.
About QMed, Inc.
QMed provides evidence-based clinical information management systems around the country to its health plan customers. The system incorporates Disease Management services to patients and decision support to physicians. The Company's QMedCare subsidiary specializes in serving high-risk populations of Medicare beneficiaries. The Company also operates a Medicare Demonstration to test the feasibility of reimbursing its care coordinated DM services in the vast Medicare fee-for-service program. More information on QMed, Inc. can be obtained at http://www.qmedinc.com, by calling (732) 544-5544 or by emailing email@example.com.
Except for historical information contained herein, matters discussed in this news release are forward-looking statements that involve risks and uncertainties. They include but are not limited to those relating to the timely implementation of programs, the impact of competitive product introductions, acceptance and pricing, and those risks detailed in the Company's filings with the Securities and Exchange Commission (SEC). Actual results may differ materially from any forward-looking statements due to these risks and uncertainties.
|SOURCE QMed, Inc.|
Copyright©2007 PR Newswire.
All rights reserved